41,204 followers
TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti–PD-1/anti–CTLA-4 immunotherapy https://t.co/iKAevpRFKh @BrighamWomens #immunotherapy #oncology
TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti–PD-1/anti–CTLA-4 immunotherapy https://t.co/iKAevpRFKh @BrighamWomens #immunotherapy #oncology
TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti-PD-1/anti-CTLA-4 immunotherapy. https://t.co/CmJBndBQFA